Immuron's fatty liver disease candidate advancing — 4 insights

Immuron is making progress on three clinical trials for IMM-124E, its nonalcoholic steatohepatitis and nonalcoholic fatty liver disease treatment. Here's what you should know.

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.